Researchers assessed whether semaglutide initiation was associated with risk for adult-onset epilepsy or seizures in adults ...

Teacher Yareli Jessica Gijon tells PEOPLE how she manages epilepsy in the classroom and why she posted a seizure video to ...

Xenon Pharmaceuticals Inc. ( XENE) Bank of America Global Healthcare Conference 2026 May 14, 2026 11:00 AM EDT ...

In a world first, a research team at the University of Zurich has successfully treated mice carrying an inherited form of ...

Ovid Therapeutics Inc. (NASDAQ:OVID) is one of the best fast growing penny stocks to buy right now. On April 9, H.C.

Bristol Myers Squibb's big buys: $18.1 billion in 2 biotech deals Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to ...

Research and Development (R&D) Expenses: R&D expense was $32.7 million for the first quarter of 2026, as compared to $19.6 million for the prior year period. The increase in R&D expense was primarily ...

A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.

While uncommon, seizures affect about 5 percent of people with multiple sclerosis. Learn about the link between MS and ...

Dr. Aziza Glass is a Doctor of Veterinary Medicine graduate from Cornell University. She was born in Houston, Texas, and nurtured her love of animals by watching television documentaries and ...

BOSTON and SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and ...

Investigational azetukalner met its primary endpoint of reducing focal onset seizure frequency across two doses, initial findings from the phase III X-TOLE2 trial showed. Over 12 weeks, adjunctive ...